Kailera Therapeutics, Inc. (KLRA)
16.40
+1.00
(+6.46%)
USD |
NASDAQ |
Sep 01, 16:00
16.40
0.00 (0.00%)
After-Hours: 19:55
Kailera Therapeutics Cash from Operations (Annual) : -120.21M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -120.21M |
| Date | Value |
|---|---|
| December 31, 2024 | -123.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Revolution Medicines, Inc. | -897.74M |
| Sana Biotechnology, Inc. | -143.83M |
| Parabilis Medicines, Inc. | -123.71M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |